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Introduction 
 
Postoperative pulmonary complications, such as 
pneumonia, atelectasis, and respiratory failure, 
are significant contributors to morbidity in pa-
tients who have undergone thoracic, cardiac, or 
upper abdominal surgery [1,2]. Recent reports 
[3,4,5,6,7,8,9] indicate that these pulmonary 
complications after surgery are at least partly 
caused by postoperative inspiratory muscle 
weakness. For instance, preoperative inspira-
tory muscle training has been shown to improve 
postoperative lung function [7] and to reduce 
the duration of postoperative mechanical venti-
lation [8]. Furthermore, recent studies [5] re-
vealed that preoperative inspiratory muscle 
training in patients undergoing cardiac surgery 
reduces the incidence of postoperative pulmo-
nary complications by ~50% and reduces the 
duration of postoperative hospitalization. 
The nature of postoperative inspiratory muscle 
weakness might include diaphragm muscle fi-
ber weakness. Recent work from our lab re-
vealed the development of marked diaphragm 
muscle fiber weakness during only two hours of 
thoracic surgery [4]. This loss of muscle fiber 
function was not part of a generalized muscle 
weakness as function was preserved in the non-
respiratory latissimus dorsi muscle. Thus, these 
findings suggested that two hours of thoracic 
surgery induces selective diaphragm muscle 
weakness through loss of function of the con-
tractile machinery within diaphragm muscle 
fibers.  
 
The mechanisms underlying the rapid develop-
ment of diaphragm muscle weakness during 
thoracic surgery is unknown, and is likely to be 
complex. Normal respiratory functions are pro-
foundly altered during general anesthesia, intra-
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Abstract: Introduction. Recent work revealed the development of marked muscle fiber weakness in the diaphragm, 
but not in the non-respiratory latissimus dorsi, during thoracic surgery. To disentangle the molecular processes that 
underlie the development of diaphragm muscle fiber weakness during thoracic surgery, we studied changes in the 
gene expression profile. Methods. Serial biopsies from the diaphragm and the latissimus dorsi muscle were obtained 
from four patients during thoracotomy for resection of a tumor in the right lung. Biopsies were taken as soon as the 
diaphragm had been exposed (t0) and again after two hours (t2). Gobal differences in gene expression in diaphragm 
biopsies were assessed by microarray analysis. Results. 346 differentially expressed gene transcripts were found in 
the diaphragm at t2 vs. t0. Pathway analysis revealed that genes associated with inflammation (83 genes; p<0.0001) 
and cell death (118 genes, p<0.0001) pathways were significantly overexpressed at t2. Of the 346 differentially ex-
pressed genes in the diaphragm at t2, 258 were also differential in the latissimus dorsi muscle, with the direction of 
change being identical for all differentially expressed genes. In addition, latissimus dorsi showed exclusive upregula-
ton of negative regulators of cell death. Conclusions. Two hours of thoracic surgery result in rapid and profound 
changes in expression of inflammatory response and apoptotic genes in the diaphragm. The apoptotic response was 
stronger in the diaphragm than in the latissiums dorsi. These findings suggest that the development of selective dia-
phragm muscle fiber weakness in these patients might be related to an exaggerated apoptotic response.  
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thoracic surgery, and mechanical ventilation. It 
is well known that anesthetics, as well as in-
flammatory mediators, such as cytokines, can 
directly affect muscle fiber function [10,11]. In 
addition, mechanical ventilation-induced inspi-
ratory muscle unloading can result in rapid dia-
phragm muscle fiber alterations, presumably 
through activation of proteolytic pathways and 
oxidative stress [12,13].  
 
In order to disentangle the complex molecular 
processes that might underlie the development 
of diaphragm muscle fiber weakness during 
thoracic surgery, we performed global gene ex-
pression profiling. We used a longitudinal ap-
proach and determined global gene expression 
in the diaphragm at the end of short-term tho-
racic surgery and compared this to that at the 
start of surgery. To test whether changes in 
gene expression are part of a generalized mus-
cle response, we also evaluated gene expres-
sion in the non-respiratory latissimus dorsi mus-
cle.  
 
Methods 
 
Patients 
 
Four patients between 53 and 72 years old un-
dergoing thoracotomy for resection of a tumor in 
the right lung were recruited for this prospec-
tive, observational, and repeated-measures de-
sign study. Biopsies from the diaphragm and 
the latissimus dorsi muscle were obtained as 
soon as the diaphragm had been exposed (t0) 
and again after two hours (t2). The biopsy loca-
tion at t0 and and t2 were ~2 cm apart. The 
exclusion criteria consisted of tumor induction 
therapy (radio- and/or chemotherapy), history of 
neuromuscular disease, chronic use of corticos-
teroids (defined as >7.5 mg/day for at least 3 
months, >10% weight loss within last 6 months, 
COPD (Global Initiative for Obstructive Lung Dis-
ease stage II-IV) or CHF (New York Heart Asso-
ciation class III-IV). Informed consent was ob-
tained from each subject, and the study was 
approved by the local ethical committee. Note 
that the four patients studied here were also 
included in a previous study [4]. 
 
Biopsy handling 
 
The fresh biopsies were blotted and rinsed to 
remove visible blood. Biopsies were stabilized 
using RNAlater solution (Ambion, Austin, TX, 
USA), and then transferred to liquid nitrogen 
and stored at -80°C until analysis.  
 
RNA extraction and microarray hybridization 
 
Total RNA was isolated from approximately 0.5 
cm3 of tissue sample by homogenization with a 
polytron bench top homogenizer (T 18 basic 
ULTRA-TURRAX®, VWR, Amsterdam, the Nether-
lands) in 3 mL of TRIzol®, and extracted accord-
ing to the manufacturers protocol (Invitrogen, 
Breda, the Netherlands). RNA integrity and con-
centrations were measured on a Bioanalyzer 
2100 (Agilent Technologies, Santa Clara, CA, 
USA) and Nanodrop spectrophotometer ND-
1000 (Fisher Scientific, Waltham, MA, USA). All 
samples were of high quality with an RNA Integ-
rity Number (RIN-value) between 7.6 and 8.7 
and 260/280 ratios greater than 2.00. 500-ng 
total RNA per sample was used as input for am-
plification and labeling with the Quick Amp La-
beling kit (Agilent Technologies, Palo Alto, CA, 
USA), and according to the manufacturer’s 
guidelines including control spikes. Labeled 
RNA was purified using the RNeasy Mini Kit 
(QIAGEN Ltd., Venlo, the Netherlands) yielding 
7.5 µg or more of labeled cRNA and specific 
activities greater than 15.3 pg Cye3 dye/µg 
cRNA and 18.9 pg Cy5 dye/µg cRNA. Labeled 
samples were hybridized onto whole human 
genome GE 4x44K microarrays according to the 
manufacturers protocol (Agilent Technologies, 
Palo Alto, CA, USA ). Scanning was performed 
using a microarray scanner G2505B (Agilent 
Technologies) and Feature Extraction v9.5 using 
the manufacturers protocols (Agilent Technolo-
gies). All samples were analyzed in duplicate. 
The microarray data have been submitted to the 
National Center for Biotechnology Information 
(NCBI) Gene Expression Omnibus database 
(GEO, database number: GSE30658) (http://
www.ncbi.nlm.nih.gov/geo).  
 
Statistical analysis  
 
All analyses of the gene expression microarray 
data were done within the R statistical software 
(http://www.r-project.org) developed by Biocon-
ductor [14], using the Limma-package. Preproc-
essing of the gene expression data comprised 
of RNA background correction, loess within-
array normalization and quantile between-array 
normalization. The moderated t-test imple-
mented in Limma, employing empirical Bayes 
estimation of the variance, is used to evaluate 
the difference in gene expression between the 
two groups. The multiplicity problem (many 
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genes are tested) is address through application 
of the Benjamini-Hochberg procedure to the raw 
p-values to control for the False Discovery Rate 
(FDR). Differences between groups were consid-
ered significantly different at p<0.01 and a 
FDR<0.1.  
 
Functional classification of genes 
 
Ingenuity Pathway Analysis (IPA, Ingenuity Sys-
tems, Redwood City, CA, USA) was used to de-
tect the biological functions and molecular net-
works of the differentially expressed (DE) genes. 
Additional functional annotation was performed 
using DAVID Bioinformatics Resources 6.7 
(NIAID/NIH). Some of the functional categories 
were combined and some categorization was 
done manually (eg., the functional categories 
‘inflammatory response’ and ‘inflammation’ 
were grouped) in order to facilitate the interpre-
tation of the data.  
 
Results 
 
Patient characteristics 
 
Patient charateristics are shown in Table 1. All 
patients underwent a thoracotomy for resection 
of a lung tumor (T1-3N0Mx). After induction of 
general anesthesia (propofol 3 mg/kg, sufen-
tanil 0.20 mg/kg) a double-lumen tube was 
placed and anesthesia was maintained with 
propofol and sufentanil. In addition, patients 
received a thoracic epidural for postoperative 
pain therapy. During single lung ventilation one 
lung was allowed to deflate while the other was 
ventilated. From the patients, biopsies (each 50
-75 mg) were taken as soon as the diaphragm 
had been exposed (t0) and again after two 
hours (t2). The diaphragm biopsies were ob-
tained from the ‘non-ventilated’ side of the dia-
phragm. The duration of mechanical ventilation 
before the first biopsy varied between 60 and 
80 minutes. Time between the first and second 
biopsies was exactly 2 hours for all four pa-
tients. Two of the four patients (#1, and 4) had 
mild airway obstruction (Table 1) and none of 
the four patients had a history of chronic heart 
failure or neuromuscular disease. All subjects 
tolerated surgery and biopsies well and no study
-related postoperative complications were 
noted. 
 
Overview of gene expression analysis 
 
Gobal differences in gene expression in dia-
phragm biopsies were assessed by microarray 
analysis. Microarray analysis identified 346 dif-
ferentially expressed (DE) gene transcripts in 
the diaphragm at t2 vs. t0. The vast majority of 
the DE genes at t2 was upregulated (326/346; 
95%). There were no noticeable differences be-
tween patients in the gene expression re-
sponse, although the limited number of patients 
did not allow for strict sub-grouping. Table 1 
shows an overview of the 15 genes that were 
most highly upregulated as well as those 5 with 
the highest downregulation. IPA was used to 
visualize the interconnectivity of the DE genes. 
In Figure 1 the network with the most DE genes 
is shown. At the center of this network are the 
pro-inflammatory mediators IL6, IL1β, CXCL2, 
and CCL2, implying a central role for these 
molecules in the muscle’s response to thoracic 
Table 1. Patient characteristics 
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surgery. Pathway analysis using IPA software 
revealed that inflammation (83 genes; 
p<0.0001) and cell death (118 genes, 
p<0.0001) pathways were significantly overrep-
resented.  
 
Next, DAVID software was used to retrieve Gene 
Ontology classifications of the differentially ex-
pressed genes. The most prominent functional 
categories were inflammatory response (45 
genes) apoptosis (108 genes). Tables 3 and 4 
show a selection, per category, of the 15 genes 
with the highest fold upregulation at t2. Genes 
within the inflammatory response functional 
category included interleukin-6 (IL6, 57 fold 
upregulated at t2), interleukin-1 beta (IL1-ß, 16 
fold upregulated at t2), and chemokine (C-C 
motif) ligand 2 (CCL2, 75 fold upregulated at 
t2).  
 
Genes upregulated within the apoptosis func-
tional category included V-myc myelocytomato-
sis viral oncogene homolog (MYC, 20 fold 
upregulated at t2) and superoxide dismutase 2 
mitochondrial (SOD2, 3 fold upregulated at t2). 
Note that several of the upregulated genes 
within the inflammatory response category were 
also grouped in the apoptosis category (eg., 
SOCS3, CCL2, IL6, CXCL2, ZFP36, CXCL1, IL1B, 
SELE; for details see Table 3). These genes are 
Figure 1. The top network of differentially expressed (DE) genes, as constructed by Ingenuity Systems Pathway Analy-
sis (IPA). Rectangles in red represent genes significantly upregulated after two hours of thoracic surgery (color inten-
sity indicates the magnitude of upregulation). White rectangles are hub molecules, of which expression is not altered, 
but that generally have many connections with DE genes. Uninterrupted and interrupted lines indicate physical and 
indirect intreactions between molecules. 
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not listed in Table 4. 
 
Gene expression analysis of m. latissimus dorsi 
from the same patients showed that of the 346 
genes that were differentially expressed in the 
diaphragm, 258 were also differentially ex-
pressed in the latissimus dorsi (Figure 2A and 
B). In addition to these 258 genes, latissimus 
dorsi showed differential expression at t2 of 
2896 other genes (Figure 2B). These 2896 
genes were mainly grouped into inflammatory 
response and apoptosis categories, and in addi-
tion, into a skeletal muscle contraction category 
(33 DE genes; top 5 (gene symbol/fold change 
at t2): MYOM1/-2, MYH2/-2, MYH3/-2, RYR1/-
2, MYLK2/-2). When these 2896 genes were 
separated into upregulated and downregulated 
genes, upregulated genes were overrepre-
Table 2. Genes with highest fold up/downregulation in the diaphragm, t2 vs t0 
Table 3. Expression of Inflammatory Response Genes in the Diaphragm, t2 vs t0 
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sented in the category negative regulation of 
programmed cell death (42 genes; p= value 5.4 
x 10-7, FDR 3.6 x 10-5), while downregulated 
genes were clustered in muscle organ develop-
ment category (29 genes; p=9.5x10-5, FDR 6.9 x 
10-2). Top 5 from negative regulation of pro-
grammed cell death are shown in Figure 2C.  
 
Discussion 
 
In the present study genome-wide gene expres-
sion profiling was used to disentangle the com-
plex molecular processes that might underlie 
the development of diaphragm muscle fiber 
weakness during thoracic surgery. It was found 
that two hours of thoracic surgery elicit a pro-
found inflammatory and pro-apoptotic response 
in the diaphragm muscle. A similar gene expres-
sion response was observed in the non-
respiratory latissimus dorsi muscle. Interest-
ingly, in addition to the upregulation of pro-
apoptotic genes, latissiums dorsi also showed 
strong upregulation of anti-apoptotic genes. This 
was not observed in diaphragm muscle. Al-
Table 4. Expression of Apoptosis-related Genes in the Diaphragm, t2 vs t0 
 
Figure 2. A. Correlation between the gene expression changes in the diaphragm and those in latissimus dorsi at t2. 
Note the strong and significant correlation. B. Venn-diagram showing the number of genes that were differential in 
both diaphragm and latissimus dorsi and the number of genes that were differential exclusively in diaphragm or in 
latissimus dorsi. C. Table listing the top 5 genes involved in negative regulation of programmed cell death that were 
differential exclusively in the latissiums dorsi at t2. 
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though future studies should validate our mi-
croarray results, these findings suggest that the 
development of selective diaphragm muscle 
fiber weakness in patients during thoracic sur-
gery [4] might be related to an exaggerated 
apoptotic response.  
 
Inflammatory response in the diaphragm during 
thoracic surgery 
 
The majority of the genes that were most 
upregulated after two hours of surgery included 
many inflammatory response genes (Tables 2 
and 3). For instance, CXCL2, IL6, SOCS3, EGR1, 
CCL2, IL1-ß, and ADAMTS4 showed a 16-80 fold 
upregulation at t2. Network analysis revealed 
that the upregulated inflammatory genes, IL6, 
IL1-ß, CXCL2, and CCL2 are key mediators that 
influence expression of many of the other DE 
genes (Figure 1). Although inflammation has 
been associated with impaired muscle fiber 
function [10,15], little data is available on the 
effects of specific inflammatory mediators on 
muscle fiber function. One of the mediators that 
gained the most attention over the past years is 
IL6, a proinflammatory cytokine that has been 
shown to impair cardiac function and to a lesser 
extent diaphragm function [16]. IL1-ß, another 
proinflammatory cytokine, has been shown to 
depress muscle contractility, presumably 
through effects on sarcoplasmic reticulum cal-
cium handling [17]. CCL2, also known as MCP-1 
(monocyte chemoattractant protein), is member 
of the CC subfamily of chemokines and has 
been shown to play an important role in the 
pathogenesis of diaphragm weakness during 
sepsis [18].   
 
Upregulation of inflammatory response genes 
has also been reported recently in human dia-
phragm muscle after five hours of cardiotho-
racic surgery [19]. In line with our findings, 
Huang et al. [19] reported upregulation of CCL2, 
IL6 , SOCS1, SOCS3, and of other inflammatory 
mediators that were also upregulated in the 
present study. Thus, upregulation of inflamma-
tory mediators appears to be a general re-
sponse of the diaphragm to thoracic surgery. 
Interestingly, the magnitude of upregulation of 
inflammatory response genes was more pro-
nounced in the present study than was reported 
by Huang et al [19]. For instance, whereas IL6 
was upregulated 16 fold during cardiothoracic 
surgery, it was upregulated nearly 60 fold in the 
present study. Similarly, CCL2 was upregulated 
8 fold in the study by Huang et al, but 75 fold in 
the present study. The mechanisms underlying 
the more pronounced inflammatory response in 
the present study might involve the time-point 
of observations. In the present study, time be-
tween biopsies was only two hours, whereas in 
the study by Huang et al. [19], time between 
biopsies was five hours. It could be speculated 
that the diaphragm undergoes a strong inflam-
matory response during the first hours of sur-
gery followed by a blunted response as time 
proceeds. However, previous work on mechani-
cally ventilated rats suggested that the gene 
expression response within the diaphragm is 
more pronounced when the duration of me-
chanical ventilaton increases [20]. Thus, these 
findings suggest that the more pronounced re-
sponse in the present study is likely not due to 
different time-points of biopsy collection, but is 
rather the result of the different conditions as-
sociated with the two types of surgeries. The 
cardiothoracic surgery, decribed in Huang et al., 
was performed under hypothermic conditions. 
Previous studies reported a reduced inflamma-
tory response within skeletal muscle following 
cold therapy [21,22]. We hypothesize that hypo-
thermia, which is not present during the lung 
surgery in the present study, blunted the inflam-
matory response within the diaphragm during 
cardiothoracic surgery.  
 
Apoptotic response in the diaphragm during 
thoracic surgery 
 
In the present study we found activation of early 
apoptotic pathways after only two hours of con-
tractile inactivity of the diaphragm. For instance, 
the proapoptotic gene MYC was upregulated 20 
fold in the diaphragm after two hours of thoracic 
surgery. Induction of apoptosis, including 
upregulation of MYC, has been described before 
in inactive muscle [23]. Furthermore, our find-
ings are in line with previous work showing sig-
nificant upregulation of apoptosis regulating 
BCL2 in the diaphragm after five hours of car-
diothoracic surgery [19]. A recent study re-
vealed activation of downstream proapoptotic 
genes in mechanically ventilated brain dead 
patients [24]. They identified induction of a Fos/
FoxO1/Stat3-Bim intrinsic apoptotic pathway 
that lead to activation of caspases following 18-
75 hours of diaphragm inactivity. Together, 
these results suggest that acute mediators of 
apoptotic pathways are rapidly activated during 
thoracic surgery, and that longer durations of 
Intraoperative diaphragmatic gene expression  
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mechanical ventilation are likely needed to sig-
nificantly activate downstream apoptotic path-
ways. 
 
Diaphragm versus latissimus dorsi gene expres-
sion during thoracic surgery 
 
An important finding of the present study was 
that the gene expression response in the latis-
simus dorsi (a non-respiratory muscle) to two 
hours of thoracic surgery was similar to that 
observed in the diaphragm (Figure 2A). Of the 
346 differential genes in the diaphragm at t2, 
258 were also differential in the latissimus dorsi 
muscle (Figure 2B), with the direction of change 
being similar for all differential genes. Analysis 
of the genes that were differential exclusively 
within the latissimus dorsi revealed that these 
genes are mainly involved in inflammatory re-
sponse and apoptotic pathways. This suggests 
that the gene expression response to thoracic 
surgery was similar in the latissimus dorsi com-
pared to the diaphragm. Interestingly, latissimus 
dorsi showed, in addition to upregulation of 
positive regulators of apoptosis, also significant 
upregulation of negative regulators of apop-
tosis. These negative regulators of apoptosis 
were not upregulated in diaphragm muscle at 
t2. Previous work from our lab showed that two 
hours of thoracic surgery induces marked dia-
phragm muscle fiber weakness [4]. This dia-
phragm muscle fiber weakness was associated 
with reduced contractile protein content and 
activation of proteolytic pathways. Strikingly, 
weakness was not observed in latissimus dorsi 
muscle fibers from the same patients. The pre-
sent findings might suggest that the develop-
ment of selective diaphragm weakness in these 
patients might be related to a stronger apop-
totic response to two hours of surgery in the 
diaphragm muscle than in the latissiums dorsi 
muscle. 
 
Conclusions 
 
This study has demonstrated that thoracic sur-
gery results in rapid changes in the expression 
of genes involved in inflammation and apop-
tosis in the diaphragm. The present study de-
sign can not rule out that other surgery related 
conditions, in addition to diaphragm inactivity, 
contributed to the changes in gene expression. 
General anesthesia and neuromuscular block-
ade have been shown to affect diaphragm 
physiology [25] and might have impacted gene 
expression in the present study. Compared to 
the non-respiratory latissimus dorsi muscle, the 
diaphragm showed a stronger apoptotic re-
sponse to two hours of thoracic surgery. There-
fore, we speculate that the development of se-
lective diaphragm muscle fiber weakness in 
these patients might be related to a more pro-
found apoptotic response.  
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